Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
As of 2026, injectable GHK-Cu is classified Category 2 by the FDA, restricting it from 503A pharmacy compounding
Another study showed that 45.8% (11/24) of patients with liver cirrhosis with minimal hepatic encephalopathy were ameliorated by l-carnitine administration for 3 months 54
**See all studies/citations on GHK 7% page here
"New Evernorth program to cap out-of-pocket costs for Wegovy, Zepbound at $200." May 21, 2025
Medications and micronutrients: identifying clinically relevant interactions and addressing nutritional needs
US$ 28.53
US$ 27.12
US$ 24.35
US$ 20.41
US$ 23.07
US$ 26.47
US$ 22.45
US$ 23.95
US$ 29.10
US$ 26.07
US$ 29.94
US$ 26.91
US$ 25.10
